The study called "REDUCE", which accompanies the vaccination in the Schwaz district due to the spread of the South African coronavirus variant, has reached many people who want to be vaccinated. 12,500 people took part in the study. Participation was offered at nine locations, and 65 percent of those vaccinated there did so. "Even 5,000 participants would have been enough to get valid results," explained study director Peter Willeit from the Med-Uni Innsbruck. </p><div> <p>The investigation period spanned six months. Data on the infection situation in the district are transmitted to the university and processed there. "We will examine in particular how much the vaccination could reduce the number of infections and the number of hospital admissions. We will also be able to assess whether the virus variant from South Africa could be almost completely suppressed," said Willeit, describing the aims of the study. The first study results should then be published in autumn.</p>
The Tyrolean politicians were just as pleased with the willingness of the population. The expectations of Governor Günther Platter (ÖVP) were “exceeded”. “In connection with vaccination coverage in Schwaz, this study also has a unique selling point in an international environment because it is the first time that an entire population group is being examined,” said Bernhard Tilg (ÖVP). Wolfgang Fleischhacker, Rector of the Med-Uni, thanked the participants: “The population in the Schwaz district has made a very important contribution to the ongoing research into SARS-CoV-2 worldwide,” he said.
At the vaccination campaign in the Schwaz district, 46,000 people took advantage of the first vaccination, a total of 64,000 would have had the opportunity. In the past week, vaccinations were carried out at 26 locations, and an exit test is still mandatory until Thursday.